MIRLET7C, microRNA let-7c, 406885

N. diseases: 154; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 Biomarker disease BEFREE An extensive review of the literature was undertaken to assess the role of hsa-let-7c in the progression of other malignancies and to evaluate its potential as a therapeutic target for PCa. 31760377 2019
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 Biomarker disease BEFREE Additional interesting findings were that the expression profiles of five miRNAs (miR-21, miR-30c, miR-129, miR-145, and let-7c) could predict poor RFS of PC, while the evaluation of miR-375 was associated with worse OS. miRNAs are important regulators in PC progression. 29095529 2018
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 Biomarker disease BEFREE Significant differences were found for let-7c in PCa in urinary exosomes while no differences were observed in urinary pellets. 27990656 2017
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 AlteredExpression disease BEFREE Expression levels of let-7c showed potential to distinguish PC patients from BPH controls with AUC=0.757, but the result did not reach significance. 25521481 2015
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 AlteredExpression disease BEFREE Furthermore, we confirmed the overexpression of the miRNAs let7c, 100 and 218 in localized prostate cancer but failed to show the control of protein expression by the putative controller miRNAs using immunohistochemistry. 23778407 2013
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 Biomarker disease BEFREE We identified miR-let-7c as a potential tumor suppressor in PCa. 22479342 2012
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.070 Biomarker disease BEFREE These results suggest that reconstitution of miR-let-7c may aid in targeting enhanced and hypersensitive AR in advanced prostate cancer. 22128178 2012